Skip Navigation



Human Molecular Genetics Advance Access published online on December 1, 2004
Human Molecular Genetics, doi:10.1093/hmg/ddi028
© 2004 by Oxford University Press
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
14/2/319    most recent
ddi028v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Frigola, J.
Right arrow Articles by Peinado, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frigola, J.
Right arrow Articles by Peinado, M. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Article

Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer

Jordi Frigola 1, Xavier Solé 2, Maria F. Paz 3, Victor Moreno 2, Manel Esteller 3, Gabriel Capellà 2, and Miguel A. Peinado 4*

1 IDIBELL-Institut de Recerca Oncològica, L'Hospitalet, Barcelona, Spain
2 IDIBELL-Institut Català d'Oncologia, L'Hospitalet, Barcelona, Spain
3 Cancer Epigenetics Laboratory, Spanish National Cancer Center (CNIO), Madrid, Spain
4 IDIBELL-Institut de Recerca Oncològica, Hospital Duran i Reynals, Granvia km 2.7, 08907 L'Hospitalet, Barcelona, Spain

* To whom correspondence should be addressed.
Miguel A. Peinado, E-mail: mpeinado{at}iro.es


  Abstract

Cancer cells are characterized by a generalized disruption of the DNA methylation pattern involving an overall decrease in the level of 5-methylcytosine together with regional hypermethylation of particular CpG islands. The extent of both DNA hypomethylation and hypermethylation in the tumor cell is likely to reflect distinctive biological and clinical features, although no studies have addressed its concurrent analysis until now. DNA methylation profiles in sporadic colorectal carcinomas, synchronous adenoma-carcinoma pairs and their matching normal mucosa were analyzed by using the Amplification of Inter-Methylated Sites (AIMS) method. A total of 208 AIMS generated sequences were tagged and evaluated for differential methylation. Global indices of hyper- and hypomethylation were calculated. All tumors displayed altered patterns of DNA methylation in reference to normal tissue. In average, 24% of the tagged sequences were differentially methylated in the tumor in regard to the normal pair with an overall prevalence of hypomethylations to hypermethylations. Carcinomas exhibited higher levels of hypermethylation than adenomas but similar levels of hypomethylation. Indices of hypomethylation and hypermethylation showed independent correlations with patient's sex, tumor staging, and specific gene hypermethylation. Hierarchical cluster analysis revealed two main patterns of DNA methylation that were associated to particular mutational spectra in the K-ras and the p53 genes and alternative correlates of hypomethylation and hypermethylation with survival. We conclude that DNA hypermethylation and hypomethylation are independent processes and appear to play different roles in colorectal tumor progression. Subgroups of colorectal tumors show specific genetic and epigenetic signatures and display distinctive correlates with overall survival.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. de Vogel, K. A.D. Wouters, R. W.H. Gottschalk, F. J. van Schooten, A. F.P.M. de Goeij, A. P. de Bruine, R. A. Goldbohm, P. A. van den Brandt, M. P. Weijenberg, and M. van Engeland
Genetic Variants of Methyl Metabolizing Enzymes and Epigenetic Regulators: Associations with Promoter CpG Island Hypermethylation in Colorectal Cancer
Cancer Epidemiol. Biomarkers Prev., November 1, 2009; 18(11): 3086 - 3096.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
S. de Vogel, M. P. Weijenberg, J. G. Herman, K. A. D. Wouters, A. F. P. M. de Goeij, P. A. van den Brandt, A. P. de Bruine, and M. van Engeland
MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events
Ann. Onc., July 1, 2009; 20(7): 1216 - 1222.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
F. Crea, E. Giovannetti, F. Cortesi, V. Mey, S. Nannizzi, M. I. Gallegos Ruiz, S. Ricciardi, M. Del Tacca, G. J. Peters, and R. Danesi
Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines
Mol. Cancer Ther., July 1, 2009; 8(7): 1964 - 1973.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
S. Ogino, K. Nosho, G. J. Kirkner, T. Kawasaki, A. T. Chan, E. S. Schernhammer, E. L. Giovannucci, and C. S. Fuchs
A Cohort Study of Tumoral LINE-1 Hypomethylation and Prognosis in Colon Cancer
J Natl Cancer Inst, December 3, 2008; 100(23): 1734 - 1738.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
T. J. Lightfoot, J. H. Barrett, T. Bishop, E. L. Northwood, G. Smith, M. J.V. Wilkie, R. J.C. Steele, F. A. Carey, T. J. Key, R. Wolf, et al.
Methylene Tetrahydrofolate Reductase Genotype Modifies the Chemopreventive Effect of Folate in Colorectal Adenoma, but not Colorectal Cancer
Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2421 - 2430.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. de Vogel, B. W.C. Bongaerts, K. A.D. Wouters, A. D.M. Kester, L. J. Schouten, A. F.P.M. de Goeij, A. P. de Bruine, R. A. Goldbohm, P. A. van den Brandt, M. van Engeland, et al.
Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer
Carcinogenesis, September 1, 2008; 29(9): 1765 - 1773.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
J. Rodriguez, L. Vives, M. Jorda, C. Morales, M. Munoz, E. Vendrell, and M. A. Peinado
Genome-wide tracking of unmethylated DNA Alu repeats in normal and cancer cells
Nucleic Acids Res., February 11, 2008; 36(3): 770 - 784.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. van den Donk, M. van Engeland, L. Pellis, B. J.M. Witteman, F. J. Kok, J. Keijer, and E. Kampman
Dietary Folate Intake in Combination with MTHFR C677T Genotype and Promoter Methylation of Tumor Suppressor and DNA Repair Genes in Sporadic Colorectal Adenomas
Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 327 - 333.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Rodriguez, J. Frigola, E. Vendrell, R.-A. Risques, M. F. Fraga, C. Morales, V. Moreno, M. Esteller, G. Capella, M. Ribas, et al.
Chromosomal Instability Correlates with Genome-wide DNA Demethylation in Human Primary Colorectal Cancers.
Cancer Res., September 1, 2006; 66(17): 8462 - 9468.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
S. M. Zhang, S. C. Moore, J. Lin, N. R. Cook, J. E. Manson, I-M. Lee, and J. E. Buring
Folate, Vitamin B6, Multivitamin Supplements, and Colorectal Cancer Risk in Women
Am. J. Epidemiol., January 15, 2006; 163(2): 108 - 115.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Matsuzaki, G. Deng, H. Tanaka, S. Kakar, S. Miura, and Y. S. Kim
The Relationship between Global Methylation Level, Loss of Heterozygosity, and Microsatellite Instability in Sporadic Colorectal Cancer
Clin. Cancer Res., December 15, 2005; 11(24): 8564 - 8569.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.